Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Gut
|
July 1, 1995
Increased leucocyte adhesiveness/aggregation is a most useful indicator of disease activity in patients with inflammatory bowel disease
N Arber, S Berliner, A Hallak, et al.
Digestive Diseases and Sciences
|
February 6, 2023
Inverse Relationship Between Clock Gene Expression and Inflammatory Markers in Ulcerative Colitis Patients Undergoing Remission
Y Weintraub, S Cohen, A Anafy, et al.
Diseases of the Colon and Rectum
|
June 1, 1996
Increased leukocyte adhesiveness/aggregation in patients with inflammatory bowel disease during remission. Further evidence for subclinical inflammation
N Arber, A Hallak, I Dotan, et al.
Liver
|
July 8, 1999
Inhibition of concanavalin A-induced acute T cell dependent hepatic damage in mice by hypothyroidism
H Shirin, I Dotan, M Papa, et al.
Genomics
|
May 1, 1997
Molecular cloning of a novel human gene encoding a 63-kDa protein and its sublocalization within the 11q13 locus
B Perelman, N Dafni, T Naiman, et al.
Alimentary Pharmacology & Therapeutics
|
February 1, 2012
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD
S Ben-Horin, Y Mazor, H Yanai, et al.
Alimentary Pharmacology & Therapeutics
|
April 20, 2016
Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis
B Ungar, Y Mazor, R Weisshof, et al.
Gut Microbes
|
October 13, 2022
Increasing adherence to the Mediterranean diet and lifestyle is associated with reduced fecal calprotectin and intra-individual changes in microbial composition of healthy subjects
L Godny, L Reshef, T Sharar Fischler, et al.
The American Journal of Gastroenterology
|
August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Gut
|
July 1, 1995
Increased leucocyte adhesiveness/aggregation is a most useful indicator of disease activity in patients with inflammatory bowel disease
N Arber, S Berliner, A Hallak, et al.
Digestive Diseases and Sciences
|
February 6, 2023
Inverse Relationship Between Clock Gene Expression and Inflammatory Markers in Ulcerative Colitis Patients Undergoing Remission
Y Weintraub, S Cohen, A Anafy, et al.
Diseases of the Colon and Rectum
|
June 1, 1996
Increased leukocyte adhesiveness/aggregation in patients with inflammatory bowel disease during remission. Further evidence for subclinical inflammation
N Arber, A Hallak, I Dotan, et al.
Liver
|
July 8, 1999
Inhibition of concanavalin A-induced acute T cell dependent hepatic damage in mice by hypothyroidism
H Shirin, I Dotan, M Papa, et al.
Genomics
|
May 1, 1997
Molecular cloning of a novel human gene encoding a 63-kDa protein and its sublocalization within the 11q13 locus
B Perelman, N Dafni, T Naiman, et al.
Alimentary Pharmacology & Therapeutics
|
February 1, 2012
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD
S Ben-Horin, Y Mazor, H Yanai, et al.
Alimentary Pharmacology & Therapeutics
|
April 20, 2016
Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis
B Ungar, Y Mazor, R Weisshof, et al.
Gut Microbes
|
October 13, 2022
Increasing adherence to the Mediterranean diet and lifestyle is associated with reduced fecal calprotectin and intra-individual changes in microbial composition of healthy subjects
L Godny, L Reshef, T Sharar Fischler, et al.
The American Journal of Gastroenterology
|
August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Page
of 5